Published in Drug Metab Dispos on November 22, 2005
Xenobiotic, bile acid, and cholesterol transporters: function and regulation. Pharmacol Rev (2010) 2.97
The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance. Biomaterials (2009) 1.37
ABC transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) expression in the developing human CNS. Neuropediatrics (2009) 1.26
Higher clearance of micafungin in neonates compared with adults: role of age-dependent micafungin serum binding. Biopharm Drug Dispos (2011) 0.93
The ontogeny of P-glycoprotein in the developing human blood-brain barrier: implication for opioid toxicity in neonates. Pediatr Res (2015) 0.89
Efflux transporters in blood-brain interfaces of the developing brain. Front Neurosci (2015) 0.75
Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J Biol Chem (2007) 2.85
Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function. Circ Res (2006) 2.33
Peroxisome proliferator-activated receptor-gamma coactivator 1alpha (PGC-1alpha) regulates triglyceride metabolism by activation of the nuclear receptor FXR. Genes Dev (2004) 2.30
Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity. J Biol Chem (2003) 2.04
The farnesoid X-receptor is an essential regulator of cholesterol homeostasis. J Biol Chem (2002) 1.97
Chemerin: at the crossroads of inflammation and obesity. Trends Endocrinol Metab (2010) 1.77
Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer. Drug Metab Dispos (2008) 1.77
Health and human rights in the Palestinian West Bank and Gaza. Lancet (2009) 1.68
Liver receptor homologue-1 mediates species- and cell line-specific bile acid-dependent negative feedback regulation of the apical sodium-dependent bile acid transporter. J Biol Chem (2002) 1.60
A procedure for creating a frailty index based on deficit accumulation in aging mice. J Gerontol A Biol Sci Med Sci (2011) 1.41
Chemerin exacerbates glucose intolerance in mouse models of obesity and diabetes. Endocrinology (2010) 1.27
Protective role of hydroxysteroid sulfotransferase in lithocholic acid-induced liver toxicity. J Biol Chem (2003) 1.19
Serum chemerin levels vary with time of day and are modified by obesity and tumor necrosis factor-{alpha}. Endocrinology (2010) 1.18
Chemerin, a novel peroxisome proliferator-activated receptor gamma (PPARgamma) target gene that promotes mesenchymal stem cell adipogenesis. J Biol Chem (2011) 1.15
Role of chemerin/CMKLR1 signaling in adipogenesis and osteoblastogenesis of bone marrow stem cells. J Bone Miner Res (2010) 1.13
Disruption of the chemokine-like receptor-1 (CMKLR1) gene is associated with reduced adiposity and glucose intolerance. Endocrinology (2011) 1.05
Urinary excretion profiles of 11-nor-9-carboxy-Delta9-tetrahydrocannabinol. Study III. A Delta9-THC-COOH to creatinine ratio study. Forensic Sci Int (2003) 1.04
Loss of functional farnesoid X receptor increases atherosclerotic lesions in apolipoprotein E-deficient mice. J Lipid Res (2005) 1.04
Early adequate mycophenolic acid exposure is associated with less rejection in kidney transplantation. Am J Transplant (2004) 1.03
Modelling complex biological systems using an agent-based approach. Integr Biol (Camb) (2011) 1.03
Chemerin: a potential endocrine link between obesity and type 2 diabetes. Endocrine (2012) 1.02
Chemerin connects fat to arterial contraction. Arterioscler Thromb Vasc Biol (2013) 0.99
Apolipoprotein A-IV is regulated by nutritional and metabolic stress: involvement of glucocorticoids, HNF-4 alpha, and PGC-1 alpha. J Lipid Res (2006) 0.98
Urinary excretion profiles of 11-nor-9-carboxy-Delta9-tetrahydrocannabinol: a Delta9-THC-COOH to creatinine ratio study #2. Forensic Sci Int (2003) 0.96
Toll-like receptor-4 regulation of hepatic Cyp3a11 metabolism in a mouse model of LPS-induced CNS inflammation. Am J Physiol Gastrointest Liver Physiol (2005) 0.96
Vitamin D receptor-dependent regulation of colon multidrug resistance-associated protein 3 gene expression by bile acids. J Biol Chem (2005) 0.96
Drug and chemical metabolites in clinical toxicology investigations: the importance of ethylene glycol, methanol and cannabinoid metabolite analyses. Clin Biochem (2002) 0.95
Type 2 diabetes and cardiovascular disease: getting to the fat of the matter. Can J Physiol Pharmacol (2007) 0.95
Phenotypic heterogeneity in pediatric autosomal dominant polycystic kidney disease at first presentation: a single-center, 20-year review. Am J Kidney Dis (2004) 0.94
Disruption of hepatic lipid homeostasis in mice after amiodarone treatment is associated with peroxisome proliferator-activated receptor-alpha target gene activation. J Pharmacol Exp Ther (2004) 0.92
Population pharmacokinetics of mycophenolic acid during the first week after renal transplantation. Eur J Clin Pharmacol (2005) 0.91
Guggulsterone: an old approach to a new problem. Trends Endocrinol Metab (2002) 0.89
The impact of bone marrow adipocytes on osteoblast and osteoclast differentiation. IUBMB Life (2014) 0.88
Urinary excretion profiles of 11-nor-9-carboxy-delta9-tetrahydrocannabinol and 11-hydroxy-delta9-THC: cannabinoid metabolites to creatinine ratio study IV. Forensic Sci Int (2004) 0.87
Predation threat exerts specific effects on rat maternal behaviour and anxiety-related behaviour of male and female offspring. Physiol Behav (2009) 0.84
Monitoring urinary excretion of cannabinoids by fluorescence-polarization immunoassay: a cannabinoid-to-creatinine ratio study. Ther Drug Monit (2002) 0.83
Chemerin neutralization blocks hematopoietic stem cell osteoclastogenesis. Stem Cells (2013) 0.81
A novel rearrangement of occludin causes brain calcification and renal dysfunction. Hum Genet (2013) 0.81
Chemokine-like receptor 1 regulates skeletal muscle cell myogenesis. Am J Physiol Cell Physiol (2012) 0.81
Elastase and tryptase govern TNFα-mediated production of active chemerin by adipocytes. PLoS One (2012) 0.81
Determination of pamidronate in human whole blood and urine by reversed-phase HPLC with fluorescence detection. Biomed Chromatogr (2004) 0.80
Neuropsychological outcome in children with acquired or congenital renal disease. Pediatr Nephrol (2002) 0.79
Effects of fluid load on human urine characteristics related to workplace drug testing. J Anal Toxicol (2012) 0.77
Effect of N-Acetylcysteine on Adipose-Derived Stem Cell and Autologous Fat Graft Survival in a Mouse Model. Plast Reconstr Surg (2015) 0.76
Influence of peroxisome proliferator-activated receptor-alpha (PPARα) activity on adverse effects associated with amiodarone exposure in mice. Pharmacol Res (2010) 0.76
Elucidation of chemerin and chemokine-like receptor-1 function in adipocytes by adenoviral-mediated shRNA knockdown of gene expression. Methods Enzymol (2009) 0.76
Acute sodium arsenite administration induces pulmonary CYP1A1 mRNA, protein and activity in the rat. J Biochem Mol Toxicol (2002) 0.76
Chipping away at gallstones. Nat Med (2004) 0.75
T-cell/periodic acid-Schiff stain: a useful tool in the evaluation of tubulointerstitial infiltrates as a component of renal allograft rejection. Ann Diagn Pathol (2002) 0.75
Paradoxical cyclosporine A requirements in pediatric renal transplants receiving high-dose steroids. J Clin Pharmacol (2005) 0.75
Current treatment of polyoma BK nephropathy in pediatric renal transplant patients. Pediatr Transplant (2008) 0.75
Two formulations of the agricultural pesticide adjuvant, Toximul, reduce the glycogen content of HepG2 cells. J Toxicol Environ Health A (2007) 0.75
The pesticide adjuvant, Toximul, alters hepatic metabolism through effects on downstream targets of PPARalpha. Biochim Biophys Acta (2007) 0.75
A comparison of the pharmacokinetics of tacrolimus and microemulsified cyclosporin in paediatric renal transplant recipients. Eur J Clin Pharmacol (2004) 0.75